Key result
Newer class III antiarrhythmic drugs are highly effective for treating patients with rhythm disorders with an acceptable degree of proarrhythmia.
Population
Patients with rhythm disorders, including atrial and ventricular arrhythmias and postoperative atrial…
Design
Review
Authors
Loading...
May prompt reevaluation of antiarrhythmic choices; leaves open need for head-to-head trials of new class III agents.
Newer class III antiarrhythmic agents that block specific or multiple ionic channels are effective for managing atrial and ventricular arrhythmias with an acceptable risk of proarrhythmia.
Philip T. Sager (1999) conducted a review in Atrial and ventricular arrhythmias. Newer class III antiarrhythmic drugs was evaluated. Newer class III antiarrhythmic drugs are highly effective for treating patients with rhythm disorders with an acceptable degree of proarrhythmia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: